Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 10630918.
- Also identified by PMC identifier 1718171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study retrospectively the effects of treatment and the clinical outcome in 12 patients with glutaric aciduria type 1; and to compare the outcome in 6 patients diagnosed as a result of family screening with 6 patients who were diagnosed late after symptomatic presentation. The National Centre for Inherited Metabolic Disorders, The Children's Hospital, Dublin, Ireland. Four of the 6 children detected on screening are developmentally normal, 1 died, and the remaining 1 has mild mental handicap. All 6 of the late diagnosed symptomatic group suffered dyskinetic cerebral palsy and 5 have died. Experience of 50 patient treatment years has shown that early intensive management can alter the natural history of this rare disorder.
Medical subject headings
- Cerebral Palsy
- Glutarates
- Metabolic Diseases